Quick Answer
NewAmsterdam Pharma Co N.V. reported Shares Outstanding of 114.40 million shares for fiscal year 2025.
NewAmsterdam Pharma Co N.V. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 114.40M | +5.9% |
| 2024 | 108.06M | +31.0% |
| 2023 | 82.47M | +1.1% |
| 2022 | 81.56M | +124.9% |
| 2022 | 36.26M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 113.17M | +22.8% | +0.6% |
| June 30, 2025 | 112.51M | +25.0% | +0.3% |
| March 31, 2025 | 112.17M | +25.0% | +3.8% |
| December 31, 2024 | 108.06M | +31.0% | +17.3% |
| September 30, 2024 | 92.17M | — | +2.4% |
| June 30, 2024 | 90.02M | — | +0.3% |
| March 31, 2024 | 89.72M | — | +8.8% |
| December 31, 2023 | 82.47M | — | — |
- NewAmsterdam Pharma Co N.V. showed an increase of +5.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, NewAmsterdam Pharma Co N.V.’s shares outstanding has grown by 215.5% (from 36.26 million shares to 114.40 million shares).
- The most recent figure is from NewAmsterdam Pharma Co N.V.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: